Talking Psychedelic-Assisted Therapy With Ricky Williams

Horizons: Perspectives on Psychedelics Conference Convenes in New York City

Settlement with US Government Allows Arizona Church to Use Ayahuasca in Religious Ceremonies

Preserving a Legacy: Wendy Tucker’s Vision for Shulgin Farm

NEWS

Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD

May 17, 2024

BetterLife’s Non-Hallucinogenic LSD Derivative Clears Safety Hurdle

May 15, 2024

Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment

May 9, 2024

Compass Pathways COMP360 Delivers on Phase 2 Results

May 9, 2024

MORE HEADLINES

Lykos Adds to Executive Team as it Ramps for Potential Launch of MDMA-Assisted Therapy

May 6, 2024

The Psychedelic Journey of Ricky Williams

April 23, 2024

Inhale, Exhale, Heal: Breathwork Can Produce Psychedelic Experiences – Without the Psychedelics

April 15, 2024

OPINION

At-Home Ketamine Therapy: Breakthrough or Breakdown?

March 21, 2024

Navigating the Psychedelic Renaissance: The Intersection of Medicine, Spirituality and Big Business

January 3, 2024

Do Psychedelic Therapists Need to Walk the Talk?

December 16, 2023

Psychedelic Therapy’s Odyssey and the Role of Spirituality

December 14, 2023

Talking Psychedelic-Assisted Therapy With Ricky Williams

Horizons: Perspectives on Psychedelics Conference Convenes in New York City

Settlement with US Government Allows Arizona Church to Use Ayahuasca in Religious Ceremonies

Preserving a Legacy: Wendy Tucker’s Vision for Shulgin Farm

NEWS

Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD

BetterLife’s Non-Hallucinogenic LSD Derivative Clears Safety Hurdle

Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment

Compass Pathways COMP360 Delivers on Phase 2 Results

MORE HEADLINES

Lykos Adds to Executive Team as it Ramps for Potential Launch of MDMA-Assisted Therapy

The Psychedelic Journey of Ricky Williams

Inhale, Exhale, Heal: Breathwork Can Produce Psychedelic Experiences – Without the Psychedelics

At-Home Ketamine Therapy: Breakthrough or Breakdown?

Navigating the Psychedelic Renaissance: The Intersection of Medicine, Spirituality and Big Business

Do Psychedelic Therapists Need to Walk the Talk?

Psychedelic Therapy’s Odyssey and the Role of Spirituality

Psilocybin

Compass Pathways COMP360 Delivers on Phase 2 Results

Psychedelics Without the Trip Show Antidepressant Potential

The Psychedelic Journey of Ricky Williams

Ketamine

FDA Approves IND Application for Freedom’s Ketamine-Based Combination Therapy

NRx Says New Formulation of IV Ketamine Could Be Delivered Subcutaneously

MIRA Pharmaceuticals Shares Encouraging Pre-Clinical Results for Ketamir-2

Ibogaine

Healing War Wounds: Stanford Explores Ibogaine’s Potential for Brain Injuries

The Ibogaine Crusader Brings the Fight to the Buckeye State

Gilgamesh Receives $14 Million NIDA Grant to Develop Ibogaine Analog for Addiction Treatment